Tumor-derived activated cells: culture conditions and characterization

Immunol Ser. 1989:48:159-73.

Authors

J R Maleckar¹, C S Friddell, W M Lewko, J R Yannelli, W H West, R K Oldham

Affiliation

¹ Biotherapeutics, Inc., Franklin, Tennessee.

PMID: 2488319

No abstract available

Publication types

Clinical Trial

MeSH terms

Cells, Cultured
Humans
Immunotherapy, Adoptive
Interleukin-2 / pharmacology
Killer Cells, Lymphokine-Activated / immunology
Lymphocyte Activation
Lymphocytes, Tumor-Infiltrating / immunology*
Neoplasms / immunology*
Neoplasms / therapy
Recombinant Proteins / pharmacology

Substances

Interleukin-2
Recombinant Proteins